Summary
68.52 -2.05(-2.90%)07/11/2025
Pampa Energía S.A. (PAM)
PAM reported last earnings on 2025-03-05 after the market. An EPS of $1.9 was observed compared to an estimated EPS of $0.00094, resulting in a surprise value of $1.90. A revenue of $439 million was observed compared to an estimated revenue of $430 million, resulting in a surprise value of $9 Million.
Pampa Energía S.A. (PAM)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| -2.90 | -0.78 | -9.62 | -1.54 | -23.51 | 46.72 | 495.83 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | A+ |
| Recommended Rating | Buy |
| DCF | Neutral |
| ROE | Buy |
| ROA | Strong Buy |
| Debt/Equity | Buy |
| P/E | Buy |
| P/B | Buy |
Earnings
| Trading Data | ||
| Close | 68.52 | |
| Open | 70.50 | |
| High | 70.57 | |
| Low | 68.31 | |
| Volume | 242,129 | |
| Change | -2.05 | |
| Change % | -2.90 | |
| Avg Volume (20 Days) | 185,403 | |
| Volume/Avg Volume (20 Days) Ratio | 1.31 | |
| 52 Week Range | 39.65 - 97.55 | |
| Price vs 52 Week High | -29.76% | |
| Price vs 52 Week Low | 72.81% | |
| Range | 0.00 | |
| Gap Up/Down | -1.85 | |
Profitibility | ||
| Market Capitalization (Mln) | 4,022 | |
| Revenue per share | 1.3744 | |
| Net Income per share | 0.3725 | |
| Dividend Yield | 0.0000 | |
| Dividend Share | 0.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 7.3585 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
06/20 03:21 EST - seekingalpha.com
Pampa Energia: A Growth Story Underestimated By The Market
Pampa Energía is leveraging Argentina's macro stabilization to consolidate its leadership in power and gas, while expanding regionally and investing in strategic LNG, shale oil, and renewables projects. Operational strength continues: thermal availability at 96%, PEPE 6 fully running, and Rincón...
Pampa Energia: A Growth Story Underestimated By The Market
Pampa Energía is leveraging Argentina's macro stabilization to consolidate its leadership in power and gas, while expanding regionally and investing in strategic LNG, shale oil, and renewables projects. Operational strength continues: thermal availability at 96%, PEPE 6 fully running, and Rincón...
06/19 01:00 EST - globenewswire.com
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced GABAB PAM Substance use disorders program successfully through IND...
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced GABAB PAM Substance use disorders program successfully through IND...
06/11 09:00 EST - businesswire.com
64GT/s PAM4 Linear ReDriver from Diodes Incorporated Delivers Enhanced Signal Quality for PCIe® 6.0 Interface Speeds
PLANO, Texas--(BUSINESS WIRE)--Diodes Incorporated (Nasdaq: DIOD) introduces the industry's first ReDriver™ to reach PCI Express® (PCIe®) 6.0 protocol speeds (up to 64 GT/s) while being backwards-compatible with PCIe 5.0/4.0/3.0 protocols. The PI3EQX64904 is a low-power, high-performance,...
64GT/s PAM4 Linear ReDriver from Diodes Incorporated Delivers Enhanced Signal Quality for PCIe® 6.0 Interface Speeds
PLANO, Texas--(BUSINESS WIRE)--Diodes Incorporated (Nasdaq: DIOD) introduces the industry's first ReDriver™ to reach PCI Express® (PCIe®) 6.0 protocol speeds (up to 64 GT/s) while being backwards-compatible with PCIe 5.0/4.0/3.0 protocols. The PI3EQX64904 is a low-power, high-performance,...
06/06 01:00 EST - globenewswire.com
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today...
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today...
05/21 10:46 EST - zacks.com
Should Value Investors Buy Pampa Energia (PAM) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Pampa Energia (PAM) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
05/21 08:26 EST - zacks.com
Reasons to Add Pampa Energia Stock to Your Portfolio Right Away
PAM makes a strong case for investment, given its growth prospects, strong ROE, liquidity, better debt management and focus on clean power generation.
Reasons to Add Pampa Energia Stock to Your Portfolio Right Away
PAM makes a strong case for investment, given its growth prospects, strong ROE, liquidity, better debt management and focus on clean power generation.
05/16 14:29 EST - seekingalpha.com
Pampa Energia S.A. (PAM) Q1 2025 Earnings Call Transcript
Pampa Energia S.A. (NYSE:PAM ) Q1 2025 Results Conference Call May 13, 2025 10:00 AM ET Company Participants Raquel Cardasz - Investor Relations Lida Wang - Investor Relations & Sustainability Officer Gustavo Mariani - Executive Vice President & Chief Executive Officer Horacio Turri - EVP &...
Pampa Energia S.A. (PAM) Q1 2025 Earnings Call Transcript
Pampa Energia S.A. (NYSE:PAM ) Q1 2025 Results Conference Call May 13, 2025 10:00 AM ET Company Participants Raquel Cardasz - Investor Relations Lida Wang - Investor Relations & Sustainability Officer Gustavo Mariani - Executive Vice President & Chief Executive Officer Horacio Turri - EVP &...
05/13 09:45 EST - seekingalpha.com
Pampa Energia: The Potential Of Argentina's Energy Sector Leader
Pampa Energía, a leading electricity producer in Argentina, holds a 15% market share and is highly diversified within the energy sector. The company operates in electric power generation, high-voltage power transmission, liquefied gas transportation, and has recently expanded into oil and gas...
Pampa Energia: The Potential Of Argentina's Energy Sector Leader
Pampa Energía, a leading electricity producer in Argentina, holds a 15% market share and is highly diversified within the energy sector. The company operates in electric power generation, high-voltage power transmission, liquefied gas transportation, and has recently expanded into oil and gas...
05/12 18:10 EST - accessnewswire.com
Pampa Energía Announces First Quarter 2025 Results
BUENOS AIRES, ARGENTINA / ACCESS Newswire / May 12, 2025 / Pampa Energía S.A. (NYSE: PAM)(Buenos Aires Stock Exchange:PAMP), an independent company with active participation in Argentine oil, gas and electricity, announces the results for the quarter ended on March 31, 2025.
Pampa Energía Announces First Quarter 2025 Results
BUENOS AIRES, ARGENTINA / ACCESS Newswire / May 12, 2025 / Pampa Energía S.A. (NYSE: PAM)(Buenos Aires Stock Exchange:PAMP), an independent company with active participation in Argentine oil, gas and electricity, announces the results for the quarter ended on March 31, 2025.
05/09 09:15 EST - zacks.com
5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PCB, GIII, ROCK, PFE and PAM hold promise.
5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PCB, GIII, ROCK, PFE and PAM hold promise.
04/29 10:45 EST - zacks.com
Are Investors Undervaluing Pampa Energia (PAM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Pampa Energia (PAM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
04/25 01:00 EST - globenewswire.com
Addex Reports Full Year 2024 Financial Results and Provides Corporate Update
Launched Neurosterix with Perceptive Advisors, raising USD 65 million in Series A to advance preclinical portfolio Indivior selected GABAB PAM drug candidate and started IND enabling studies for development in substance use disorders Addex selected independent GABAB PAM drug candidate for...
Addex Reports Full Year 2024 Financial Results and Provides Corporate Update
Launched Neurosterix with Perceptive Advisors, raising USD 65 million in Series A to advance preclinical portfolio Indivior selected GABAB PAM drug candidate and started IND enabling studies for development in substance use disorders Addex selected independent GABAB PAM drug candidate for...
04/24 11:24 EST - 247wallst.com
3 Utility Stocks Set to Deliver 20%+ Returns in 2025
Utility stocks have long been a favorite for investors who are looking for stability and consistent returns in the current market.
3 Utility Stocks Set to Deliver 20%+ Returns in 2025
Utility stocks have long been a favorite for investors who are looking for stability and consistent returns in the current market.
04/22 13:00 EST - zacks.com
All You Need to Know About Pampa (PAM) Rating Upgrade to Strong Buy
Pampa (PAM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About Pampa (PAM) Rating Upgrade to Strong Buy
Pampa (PAM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
04/22 08:25 EST - zacks.com
New Strong Buy Stocks for April 22nd
DPMLF, PAM, MTAL, HRTX and BALY have been added to the Zacks Rank #1 (Strong Buy) List on April 22, 2025.
New Strong Buy Stocks for April 22nd
DPMLF, PAM, MTAL, HRTX and BALY have been added to the Zacks Rank #1 (Strong Buy) List on April 22, 2025.
04/22 05:10 EST - zacks.com
Best Value Stocks to Buy for April 22nd
AES, PAM and DPMLF made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 22, 2025.
Best Value Stocks to Buy for April 22nd
AES, PAM and DPMLF made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 22, 2025.
04/17 09:00 EST - globenewswire.com
Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative new treatment to accelerate chronic wound healing. A multi-year exclusive agreement between PAM Health and Nuo Therapeutics, Inc....
Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative new treatment to accelerate chronic wound healing. A multi-year exclusive agreement between PAM Health and Nuo Therapeutics, Inc....
04/17 01:00 EST - globenewswire.com
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that...
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that...
04/16 12:30 EST - accessnewswire.com
Pampa Energia Informs that it has Filed its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
BUENOS AIRES, AR / ACCESS Newswire / April 16, 2025 / Pampa Energía S.A. (NYSE: PAM)(Buenos Aires Stock Exchange:PAMP) (‘Pampa' or the ‘Company'), one of the leading energy companies in Argentina, with participation in the oil and gas and electricity value chain, announces that on April 16,...
Pampa Energia Informs that it has Filed its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
BUENOS AIRES, AR / ACCESS Newswire / April 16, 2025 / Pampa Energía S.A. (NYSE: PAM)(Buenos Aires Stock Exchange:PAMP) (‘Pampa' or the ‘Company'), one of the leading energy companies in Argentina, with participation in the oil and gas and electricity value chain, announces that on April 16,...